Zevin Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
|
|||||
2022
Q3 | $1.58M | Sell |
|
|||||
2022
Q2 | $3.04M | Buy |
|
|||||
2022
Q1 | $2.37M | Buy |
|
|||||
2021
Q4 | $1.7M | Buy |
|
|||||
2021
Q3 | $1.31M | Buy |
|
|||||
2021
Q2 | $1.14M | Buy |
|
|||||
2021
Q1 | $1.02M | Buy |
|
|||||
2020
Q4 | $907K | Buy |
|
|||||
2020
Q3 | $838K | Hold |
|
|||||
2020
Q2 | $909K | Buy |
|
|||||
2020
Q1 | $815K | Buy |
|
|||||
2019
Q4 | $977K | Sell |
|
|||||
2019
Q3 | $969K | Sell |
|
|||||
2019
Q2 | $1.08M | Sell |
|
|||||
2019
Q1 | $1.36M | Sell |
|
|||||
2018
Q4 | $1.26M | Sell |
|
|||||
2018
Q3 | $1.45M | Sell |
|
|||||
2018
Q2 | $1.46M | Sell |
|
|||||
2018
Q1 | $1.69M | Sell |
|
|||||
2017
Q4 | $2.43M | Buy |
|
|||||
2017
Q3 | $2.24M | Buy |
|
|||||
2017
Q2 | $2.35M | Sell |
|
|||||
2017
Q1 | $2.42M | Sell |
|
|||||
2016
Q4 | $2.86M | Buy |
|
|||||
2016
Q3 | $3.15M | Sell |
|
|||||
2016
Q2 | $3.38M | Buy |
|
|||||
2016
Q1 | $2.48M | Sell |
|
|||||
2015
Q4 | $2.77M | Buy |
|
|||||
2015
Q3 | $2.54M | Buy |
|
|||||
2015
Q2 | $2.68M | Buy |
|
|||||
2015
Q1 | $2.95M | Sell |
|
|||||
2014
Q4 | $2.75M | Buy |
|